Login
$GOVX
$0.20 -$0.00 (1.44%) Close

$GOVX 3 SEC Filings

Filed On Filing
27 Dec 2022 Form 3: Morgan Jayne, Director

No securities owned

06 Sep 2022 Form 3: Lemerond Nicole, Director

No securities owned

22 Jun 2022 Form 3: Sharkey John W., VP, Business Development

Holds 1,860 shares of Common Stock

11 Jan 2022 Form 3: McKee Kelly T. Jr., Chief Medical Officer

No securities owned

03 Sep 2020 Form 3: Newman Mark J, Chief Scientific Officer

No securities owned

26 Oct 2015 Form 3: Guirakhoo Farshad, Sr VP, Research & Development
23 Mar 2015 Form 3: Chase Randal D, Director

Holds 0 shares of Common Stock

23 Mar 2010 Form 3: Dodd David A, Director

Holds 0 shares of Common Stock

19 Mar 2010 Form 3: Antebi Steven S., Director

Holds 0 shares of Common Stock

06 Jan 2010 Form 3: Newman Mark J, VP, Research & Development
22 Aug 2008 Form 3: Tsolinas Peter M, Director

Holds 23,486,734 shares of Common Stock

13 Dec 2006 Form 3: Mcnally Robert T, Director

Holds 617,742 shares of Common Stock

16 Oct 2006 Form 3: Kollintzas Dean G, Director

No securities owned

11 Oct 2006 Form 3: Reynolds Mark, CFO and Secretary

No securities owned

11 Oct 2006 Form 3: Teal Gary, Director

No securities owned

10 Oct 2006 Form 3: Emory University, 10% owner

Holds 233,905,253 shares of Common Stock

10 Oct 2006 Form 3: Robinson Harriet L, Chair of Scientific Advisory

Holds 60,426,235 shares of Common Stock

10 Oct 2006 Form 3: Murphree Edith, Director

No securities owned

10 Oct 2006 Form 3: Hildebrand Donald G, Director

Holds 59,182,847 shares of Common Stock

10 Oct 2006 Form 3: Spencer John N Jr, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support